Perkins Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$603K	Sell	7,841 -600	-7%	-$46.8K	0.57%	51
2025 Q4	$666K	Hold	8,441	–	–	0.53%	49
2025 Q3	$773K	Hold	8,441	–	–	0.68%	41
2025 Q2	$551K	Hold	8,441	–	–	0.55%	45
2025 Q1	$565K	Hold	8,441	–	–	0.6%	48
2024 Q4	$467K	Sell	8,441 -750	-8%	-$43.1K	0.41%	60
2024 Q3	$548K	Hold	9,191	–	–	0.51%	55
2024 Q2	$585K	Hold	9,191	–	–	0.55%	56
2024 Q1	$635K	Hold	9,191	–	–	0.53%	57
2023 Q4	$507K	Hold	9,191	–	–	0.43%	61
2023 Q3	$534K	Hold	9,191	–	–	0.53%	53
2023 Q2	$495K	Buy	9,191 +665	+8%	+$29.5K	0.43%	59
2023 Q1	$339K	Hold	8,526	–	–	0.32%	69
2022 Q4	$343K	Hold	8,526	–	–	0.36%	66
2022 Q3	$274K	Sell	8,526 -900	-10%	-$30.8K	0.31%	73
2022 Q2	$280K	Hold	9,426	–	–	0.29%	72
2022 Q1	$265K	Sell	9,426 -1,500	-14%	-$55.9K	0.22%	83
2021 Q4	$503K	Sell	10,926 -3,150	-22%	-$135K	0.34%	73
2021 Q3	$462K	Hold	14,076	–	–	0.29%	74
2021 Q2	$493K	Sell	14,076 -590	-4%	-$20.1K	0.28%	76
2021 Q1	$530K	Buy	+14,666	New	+$459K	0.31%	72
2020 Q1	–	Sell	-11,491	Closed	-$709K	–	109
2019 Q4	$709K	Sell	11,491 -11,292	-50%	-$748K	0.64%	54
2019 Q3	$1.66M	Sell	22,783 -7,017	-24%	-$525K	1.43%	24
2019 Q2	$2.45M	Sell	29,800 -2,750	-8%	-$196K	1.72%	19
2019 Q1	$2.3M	Sell	32,550 -150	-0.5%	-$8.82K	1.51%	18
2018 Q4	$1.47M	Sell	32,700 -250	-0.8%	-$13.1K	1.14%	24
2018 Q3	$1.86M	Buy	32,950 +1,950	+6%	+$119K	1.12%	27
2018 Q2	$2.07M	Buy	31,000 +4,000	+15%	+$250K	1.48%	12
2018 Q1	$1.57M	Hold	27,000	–	–	1.42%	15
2017 Q4	$1.74M	Buy	27,000 +7,200	+36%	+$448K	1.67%	13
2017 Q3	$1.04M	Sell	19,800 -1,750	-8%	-$83.4K	1.09%	31
2017 Q2	$1.01M	Sell	21,550 -600	-3%	-$28.9K	1.12%	25
2017 Q1	$1.1M	Buy	+22,150	New	+$1.24M	1.13%	26